Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys

Journal of Sexual Medicine

Volumn 8, Issue 11, 2011, Pages 3051-3057

  Travison, Thomas G ^a,b   Hall, Susan A ^a   Fisher, William A ^c   Araujo, Andre B ^a   Rosen, Raymond C ^a   McKinlay, John B ^a   Sand, Michael S ^d  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Aging; Epidemiology; Sexual dysfunction

Indexed keywords

CHOLESTEROL; PHOSPHODIESTERASE V INHIBITOR;

ADULT; AGE; AGED; ARTICLE; BODY COMPOSITION; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; ERECTILE DYSFUNCTION; FOLLOW UP; HEALTH SURVEY; HEART DISEASE; HUMAN; HYPERTENSION; INCOME; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUALITY; SOCIAL STATUS; SYMPTOM;

EID: 80255138854     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02423.x     Document Type: Article

References (32)

1. Aytaç IA, Araujo AB, Johannes CB, Kleinman KP, McKinlay JB. Socioeconomic factors and incidence of erectile dysfunction: Findings of the longitudinal Massachusetts Male Aging Study. Soc Sci Med 2000;51:771-8.
2. Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JLHR. Prevalence of erectile dysfunction: A systematic review of population-based studies. Int J Impot Res 2002;14:422-32.
3. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006;166:207-12.
4. Segraves RT, Knopf J, Camic P. Spontaneous remission in erectile impotence. Behav Res Ther 1982;20:89-91.
5. Segraves RT, Camic P, Ivanoff J. Spontaneous remission in erectile dysfunction: A partial replication. Behav Res Ther 1985;23:203-4.
6. Travison TG, Shabsigh R, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB. The natural progression and remission of erectile dysfunction: Results from the Massachusetts Male Aging Study. J Urol 2007;177:241-6; discussion 246.
7. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study. J Urol 2000;163:460-3.
8. Hannan JL, Maio MT, Komolova M, Adams MA. Beneficial impact of exercise and obesity interventions on erectile function and its risk factors. J Sex Med 2009;6(suppl 3):254-61.
9. Wing RR, Rosen RC, Fava JL, Bahnson J, Brancati F, Gendrano Iii INCIN, Kitabchi A, Schneider SH, Wadden TA. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD Trial. J Sex Med 2010 Jan;7(1 Pt 1):156-65.
10. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk? Urology 2000;56:302-6.
11. Tan HM, Low WY, Ng CJ, Chen KK, Sugita M, Ishii N, Marumo K, Lee SW, Fisher W, Sand M. Prevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian Men: The Asian Men's Attitudes to Life Events and Sexuality (MALES) study. J Sex Med 2007;4:1582-92.
12. Axilrod AC. Phosphodiesterase type 5 inhibitor therapy: Identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction. Curr Med Res Opin 2007;23:3189-98.
13. Nehra A. Erectile dysfunction and cardiovascular disease: Efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clin Proc 2009;84:139-48.
14. Rosen RC, Wing R, Schneider S, Gendrano N. Epidemiology of erectile dysfunction: The role of medical comorbidities and lifestyle factors. Urol Clin North Am 2005;32:403-17, v.
15. Fisher WA, Rosen RC, Eardley I, Niederberger C, Nadel A, Kaufman J, Sand M The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: Understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med 2004;1:150-60.
16. Shabsigh R, Perelman MA, Laumann EO, Lockhart DC. Drivers and barriers to seeking treatment for erectile dysfunction: A comparison of six countries. BJU Int 2004;94:1055-65.
17. Sand MS, Fisher W, Rosen R, Heiman J, Eardley I. Erectile dysfunction and constructs of masculinity and quality of life in the multinational Men's Attitudes to Life Events and Sexuality (MALES) study. J Sex Med 2008;5:583-94.
18. Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples I: Couple conceptions of ED. J Sex Med 2009;6:2746-60.
19. Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005;2:675-84.
20. McKinlay JB, Link CL. Measuring the urologic iceberg: Design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol 2007;52:389-96.
21. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
22. O'Donnell AB, Araujo AB, Goldstein I, McKinlay JB. The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med 2005;20:515-9.
23. Wallman KK, Evinger S, Schechter S. Measuring our nation's diversity: Developing a common language for data on race/ethnicity. Am J Public Health 2000;90:1704-8.
24. Green LW. Manual for scoring socioeconomic status for research on health behavior. Public Health Rep 1970;85:815-27.
25. Turvey CL, Wallace RB, Herzog R. A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Int Psychogeriatr 1999;11:139-48.
26. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
27. Rubin DB, Schenker N. Multiple imputation in health-care databases: An overview and some applications. Stat Med 1991;10:585-98.
28. Araujo AB, Travison TG, Ganz P, Chiu GR, Kupelian V, Rosen RC, Hall SA, McKinlay JB. Erectile dysfunction and mortality. J Sex Med 2009;6:2445-54.
29. Billups KL. Sexual dysfunction and cardiovascular disease: Integrative concepts and strategies. Am J Cardiol 2005;96:57M-61M.
30. Kirby M, Jackson G, Simonsen U. Endothelial dysfunction links erectile dysfunction to heart disease. Int J Clin Pract 2005;59:225-9.
31. Guay AT. ED2: Erectile dysfunction=endothelial dysfunction. Endocrinol Metab Clin North Am 2007;36:453-63.
32. Kapur V, Chien CV, Fuess JE, Schwarz ER. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease. Rev Cardiovasc Med 2008;9:187-95.